CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Clinical trials for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) explained in plain language.
Never miss a new study
Get alerted when new CLL (CHRONIC LYMPHOCYTIC LEUKEMIA) trials appear
Sign up with your email to follow new studies for CLL (CHRONIC LYMPHOCYTIC LEUKEMIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Tough-to-Treat blood cancers: rocbrutinib takes on pirtobrutinib in Head-to-Head trial
Disease control Recruiting nowThis study tests a new oral drug, rocbrutinib, against another drug, pirtobrutinib, in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has returned or not responded after prior treatment with a BTK inhibitor. About 306 participants …
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 26, 2026 04:20 UTC
-
New drug cocktails aim to tame deadly transplant complication
Disease control Recruiting nowThis study is for people with blood cancers who need a stem cell transplant from an unrelated donor with a different blood type. The goal is to find which drug combination works best to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the …
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Could bone marrow from deceased donors offer a new lifeline for blood cancer patients?
Disease control Recruiting nowThis early-phase study is testing whether bone marrow from deceased donors can be safely used for transplants in people with blood cancers like leukemia and lymphoma. About 12 patients will receive either strong or milder chemotherapy before the transplant. Researchers will monit…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Plant-Based diet trial hopes to slow Early-Stage leukemia
Disease control Recruiting nowThis study looks at whether a short-term whole-food, plant-based diet can change how the immune system works and affect disease activity in people with early-stage chronic lymphocytic leukemia (CLL) who have not yet had treatment. About 50 participants will follow the diet for 4 …
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New hope for hard-to-treat blood cancers: experimental drug enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called ZE50-0134 in about 66 adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or certain low-grade lymphomas that have returned or not responded to prior therapies. The main goals are to check the drug's safety and how …
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
No treatment, just watching: new study tracks blood cancers over years
Knowledge-focused Recruiting nowThis study follows up to 1,000 adults with certain blood cancers (CLL, SLL, LPL, or WM) to learn how these diseases change over time. Participants get regular check-ups, blood tests, and optional scans or biopsies, but no treatment is given. The goal is to better understand the d…
Matched conditions: CLL (CHRONIC LYMPHOCYTIC LEUKEMIA)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 04:09 UTC